Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Radiopharmaceuticals in Nuclear Medical market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Radiopharmaceuticals in Nuclear Medicalmarket, defines the market attractiveness level of Radiopharmaceuticals in Nuclear Medical market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Radiopharmaceuticals in Nuclear Medical industry, describes the types of Radiopharmaceuticals in Nuclear Medical market, the applications of major players and the market size, and deeply analyzes the current situation of the global Radiopharmaceuticals in Nuclear Medical market and the development prospects and opportunities of Radiopharmaceuticals in Nuclear Medical industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Radiopharmaceuticals in Nuclear Medical market in Chapter 13.
By Player:
Cardinal Health
Eczacibasi-Monrol
Bracco Imaging
IBA Group
Ntp Radioisotopes
Urenco Limited
Rotem Industries
Fujifilm Holdings Corporation
Taiyo Nippon Sanso Corporation
Nordion
Lantheus Medical Imaging
Siemens Healthcare
Cambridge Isotope Laboratories
Covidien
GE Healthcare (Subsidiary Of General Electric Company)
By Type:
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
By End-User:
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Industrial
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Radiopharmaceuticals in Nuclear Medical Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Radiopharmaceuticals in Nuclear Medical Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Radiopharmaceuticals in Nuclear Medical Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Radiopharmaceuticals in Nuclear Medical Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Radiopharmaceuticals in Nuclear Medical Market Analysis and Outlook to 2022
-
7.1 Global Radiopharmaceuticals in Nuclear Medical Consumption (2017-2022)
-
7.2 United States Radiopharmaceuticals in Nuclear Medical Consumption (2017-2022)
-
7.3 Europe Radiopharmaceuticals in Nuclear Medical Consumption (2017-2022)
-
7.4 China Radiopharmaceuticals in Nuclear Medical Consumption (2017-2022)
-
7.5 Japan Radiopharmaceuticals in Nuclear Medical Consumption (2017-2022)
-
7.6 India Radiopharmaceuticals in Nuclear Medical Consumption (2017-2022)
-
7.7 South Korea Radiopharmaceuticals in Nuclear Medical Consumption (2017-2022)
8 Region and Country-wise Radiopharmaceuticals in Nuclear Medical Market Analysis and Outlook to 2028
-
8.1 Global Radiopharmaceuticals in Nuclear Medical Consumption Forecast (2022-2028)
-
8.2 United States Radiopharmaceuticals in Nuclear Medical Consumption Forecast (2022-2028)
-
8.3 Europe Radiopharmaceuticals in Nuclear Medical Consumption Forecast (2022-2028)
-
8.4 China Radiopharmaceuticals in Nuclear Medical Consumption Forecast (2022-2028)
-
8.5 Japan Radiopharmaceuticals in Nuclear Medical Consumption Forecast (2022-2028)
-
8.6 India Radiopharmaceuticals in Nuclear Medical Consumption Forecast (2022-2028)
-
8.7 South Korea Radiopharmaceuticals in Nuclear Medical Consumption Forecast (2022-2028)
9 Global Radiopharmaceuticals in Nuclear Medical Market Outlook by Types and Applications to 2022
-
9.1 Global Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Therapy Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Enriched Stable Isotopes Consumption and Growth Rate (2017-2022)
-
9.2 Global Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Diagnostic Application Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Therapeutic Application Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Research Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Pharmaceutical Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Industrial Consumption and Growth Rate (2017-2022)
10 Global Radiopharmaceuticals in Nuclear Medical Market Outlook by Types and Applications to 2028
-
10.1 Global Radiopharmaceuticals in Nuclear Medical Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Therapy Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Enriched Stable Isotopes Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Radiopharmaceuticals in Nuclear Medical Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Diagnostic Application Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Therapeutic Application Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Research Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Industrial Consumption Forecast and Growth Rate (2022-2028)
11 Global Radiopharmaceuticals in Nuclear Medical Import and Export Analysis (Top 5 Countries)
-
11.1 Global Radiopharmaceuticals in Nuclear Medical Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Radiopharmaceuticals in Nuclear Medical Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Radiopharmaceuticals in Nuclear Medical Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Radiopharmaceuticals in Nuclear Medical Market Competitive Analysis
-
14.1 Cardinal Health
-
14.1.1 Cardinal Health Company Details
-
14.1.2 Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Cardinal Health Radiopharmaceuticals in Nuclear Medical Product and Service
-
14.2 Eczacibasi-Monrol
-
14.2.1 Eczacibasi-Monrol Company Details
-
14.2.2 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Product and Service
-
14.3 Bracco Imaging
-
14.3.1 Bracco Imaging Company Details
-
14.3.2 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Product and Service
-
14.4 IBA Group
-
14.4.1 IBA Group Company Details
-
14.4.2 IBA Group Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 IBA Group Radiopharmaceuticals in Nuclear Medical Product and Service
-
14.5 Ntp Radioisotopes
-
14.5.1 Ntp Radioisotopes Company Details
-
14.5.2 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Product and Service
-
14.6 Urenco Limited
-
14.6.1 Urenco Limited Company Details
-
14.6.2 Urenco Limited Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Urenco Limited Radiopharmaceuticals in Nuclear Medical Product and Service
-
14.7 Rotem Industries
-
14.7.1 Rotem Industries Company Details
-
14.7.2 Rotem Industries Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Rotem Industries Radiopharmaceuticals in Nuclear Medical Product and Service
-
14.8 Fujifilm Holdings Corporation
-
14.8.1 Fujifilm Holdings Corporation Company Details
-
14.8.2 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Product and Service
-
14.9 Taiyo Nippon Sanso Corporation
-
14.9.1 Taiyo Nippon Sanso Corporation Company Details
-
14.9.2 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Product and Service
-
14.10 Nordion
-
14.10.1 Nordion Company Details
-
14.10.2 Nordion Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Nordion Radiopharmaceuticals in Nuclear Medical Product and Service
-
14.11 Lantheus Medical Imaging
-
14.11.1 Lantheus Medical Imaging Company Details
-
14.11.2 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Product and Service
-
14.12 Siemens Healthcare
-
14.12.1 Siemens Healthcare Company Details
-
14.12.2 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Product and Service
-
14.13 Cambridge Isotope Laboratories
-
14.13.1 Cambridge Isotope Laboratories Company Details
-
14.13.2 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Product and Service
-
14.14 Covidien
-
14.14.1 Covidien Company Details
-
14.14.2 Covidien Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Covidien Radiopharmaceuticals in Nuclear Medical Product and Service
-
14.15 GE Healthcare (Subsidiary Of General Electric Company)
-
14.15.1 GE Healthcare (Subsidiary Of General Electric Company) Company Details
-
14.15.2 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Radiopharmaceuticals in Nuclear Medical
-
Figure Radiopharmaceuticals in Nuclear Medical Picture
-
Table Global Radiopharmaceuticals in Nuclear Medical Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Radiopharmaceuticals in Nuclear Medical Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Radiopharmaceuticals in Nuclear Medical Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Radiopharmaceuticals in Nuclear Medical Consumption by Country (2017-2022)
-
Figure United States Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2017-2022)
-
Table Europe Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2017-2022)
-
Figure China Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2017-2022)
-
Figure Japan Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2017-2022)
-
Figure India Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2017-2022)
-
Figure South Korea Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2017-2022)
-
Figure Global Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Country (2022-2028)
-
Figure United States Radiopharmaceuticals in Nuclear Medical Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Radiopharmaceuticals in Nuclear Medical Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Radiopharmaceuticals in Nuclear Medical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Radiopharmaceuticals in Nuclear Medical Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Radiopharmaceuticals in Nuclear Medical Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Radiopharmaceuticals in Nuclear Medical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Global Therapy Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Global Enriched Stable Isotopes Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic Application Consumption and Growth Rate (2017-2022)
-
Figure Global Therapeutic Application Consumption and Growth Rate (2017-2022)
-
Figure Global Research Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Global Industrial Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Therapy Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Enriched Stable Isotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic Application Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Therapeutic Application Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Industrial Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Radiopharmaceuticals in Nuclear Medical Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Radiopharmaceuticals in Nuclear Medical Export by Region (Top 5 Countries) (2017-2028)
-
Table Cardinal Health (Foundation Year, Company Profile and etc.)
-
Table Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cardinal Health Radiopharmaceuticals in Nuclear Medical Product and Service
-
Table Eczacibasi-Monrol (Foundation Year, Company Profile and etc.)
-
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Product and Service
-
Table Bracco Imaging (Foundation Year, Company Profile and etc.)
-
Table Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bracco Imaging Radiopharmaceuticals in Nuclear Medical Product and Service
-
Table IBA Group (Foundation Year, Company Profile and etc.)
-
Table IBA Group Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
Table IBA Group Radiopharmaceuticals in Nuclear Medical Product and Service
-
Table Ntp Radioisotopes (Foundation Year, Company Profile and etc.)
-
Table Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Product and Service
-
Table Urenco Limited (Foundation Year, Company Profile and etc.)
-
Table Urenco Limited Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Urenco Limited Radiopharmaceuticals in Nuclear Medical Product and Service
-
Table Rotem Industries (Foundation Year, Company Profile and etc.)
-
Table Rotem Industries Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Rotem Industries Radiopharmaceuticals in Nuclear Medical Product and Service
-
Table Fujifilm Holdings Corporation (Foundation Year, Company Profile and etc.)
-
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Product and Service
-
Table Taiyo Nippon Sanso Corporation (Foundation Year, Company Profile and etc.)
-
Table Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Product and Service
-
Table Nordion (Foundation Year, Company Profile and etc.)
-
Table Nordion Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nordion Radiopharmaceuticals in Nuclear Medical Product and Service
-
Table Lantheus Medical Imaging (Foundation Year, Company Profile and etc.)
-
Table Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Product and Service
-
Table Siemens Healthcare (Foundation Year, Company Profile and etc.)
-
Table Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Product and Service
-
Table Cambridge Isotope Laboratories (Foundation Year, Company Profile and etc.)
-
Table Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Product and Service
-
Table Covidien (Foundation Year, Company Profile and etc.)
-
Table Covidien Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Covidien Radiopharmaceuticals in Nuclear Medical Product and Service
-
Table GE Healthcare (Subsidiary Of General Electric Company) (Foundation Year, Company Profile and etc.)
-
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales, Price, Value and Gross Profit (2017-2022)
-
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Product and Service
-
